Alicia Montanez, MD
Clinical Cardiac Electrophysiology · Anaheim, CANPI 1326219783
Payments from drug & device makers
Across 48 payments — averaging $49.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Abbott$271
- Biosense Webster, Inc.$82
- Kestra Medical Technology Services, Inc.$73
- Kiniksa Pharmaceuticals International, PLC$35
- Teleflex LLC$34
- plus $100 from 5 others
What the payments were for
- Travel & lodging$1,33256%
- Food & beverage$1,05244%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 27 | $1,789 |
| Abbott | 5 | $271 |
| Biosense Webster, Inc. | 4 | $82 |
| Kestra Medical Technology Services, Inc. | 4 | $73 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $35 |
| Teleflex LLC | 2 | $34 |
| Boston Scientific | 1 | $23 |
| Philips North America LLC | 1 | $23 |
| Chiesi USA, Inc. | 1 | $23 |
| GE HealthCare | 1 | $17 |
| Astellas Pharma US Inc | 1 | $15 |
How this compares
$2,385 in reported general payments places this provider in the 5th percentile of 290 clinical cardiac electrophysiology providers in California.
See all clinical cardiac electrophysiology providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 131 | $112,046 |
| XareltoRivaroxaban | 27 | $22,528 |
| Amiodarone Hcl | 59 | $3,057 |
| Metoprolol Succinate | 201 | $2,754 |
| SotalolSotalol Hcl | 85 | $2,108 |
| Mexiletine Hcl | 11 | $1,798 |
| Flecainide Acetate | 31 | $836 |
| Hydralazine Hcl | 27 | $443 |
| Losartan Potassium | 34 | $424 |
| Valsartan | 12 | $418 |
| Pantoprazole Sodium | 54 | $409 |
| Diltiazem 24hr ErDiltiazem Hcl | 16 | $400 |
| Amlodipine Besylate | 67 | $347 |
| Carvedilol | 65 | $290 |
| Metoprolol Tartrate | 16 | $169 |
Paid to pharmacies, not to this prescriber.
Other clinical cardiac electrophysiology in Anaheim
- David KrummenSan Diego$7.3M
- Jonathan DukesVentura$2.9M
- Shephal DoshiSanta Monica$2.9M
- Arash AryanaSacramento$2.4M
- Marco PerezStanford$2.1M
- Rahul DoshiLos Angeles$2M
- Mayer RashtianPasadena$1.8M
- Rajesh BankerNewport Beach$1.6M
- Edward GerstenfeldSan Francisco$1.5M
- Jonathan HsuSan Diego$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.